05:37 PM EDT, 06/11/2025 (MT Newswires) -- Eben Tessari, COO, on June 09, 2025, sold 70,867 shares in Kiniksa Pharmaceuticals International ( KNSA ) for $2,160,035. Following the Form 4 filing with the SEC, Tessari has control over a total of 72,363 Class A common shares of the company, with 72,363 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1730430/000141588925016722/xslF345X05/form4-06112025_090628.xml